LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
BT-20 NU7441
1.11
uM
LJP5
 0.9664 0.0219 0.9583 0.0282
BT-20 NU7441
3.33
uM
LJP5
 0.8782 0.0483 0.8533 0.0563
BT-20 NU7441
10
uM
LJP5
 0.4572 0.0716 0.2630 0.0950
BT-20 OSI-027
0.04
uM
LJP6
 1.0066 0.0237 1.0074 0.0281
BT-20 OSI-027
0.12
uM
LJP6
 0.8388 0.0471 0.8001 0.0553
BT-20 OSI-027
0.37
uM
LJP6
 0.6992 0.0557 0.6128 0.0665
BT-20 OSI-027
1.11
uM
LJP6
 0.6030 0.0440 0.4757 0.0516
BT-20 OSI-027
3.33
uM
LJP6
 0.5059 0.0383 0.3271 0.0423
BT-20 OSI-027
10
uM
LJP6
 0.3958 0.0242 0.1445 0.0308
BT-20 WYE-125132
0.04
uM
LJP6
 0.6014 0.0776 0.4727 0.0999
BT-20 WYE-125132
0.12
uM
LJP6
 0.4699 0.0500 0.2691 0.0639
BT-20 WYE-125132
0.37
uM
LJP6
 0.4329 0.0382 0.2083 0.0484
BT-20 WYE-125132
1.11
uM
LJP6
 0.3990 0.0301 0.1503 0.0368
BT-20 WYE-125132
3.33
uM
LJP6
 0.3779 0.0302 0.1132 0.0436
BT-20 WYE-125132
10
uM
LJP6
 0.3398 0.0326 0.0435 0.0495
BT-20 Barasertib
0.04
uM
LJP5
 0.8418 0.0530 0.8061 0.0644
BT-20 Barasertib
0.12
uM
LJP5
 0.6688 0.0698 0.5746 0.0952
BT-20 Barasertib
0.37
uM
LJP5
 0.5400 0.0364 0.3920 0.0696
BT-20 Barasertib
1.11
uM
LJP5
 0.4355 0.0265 0.2284 0.0674
BT-20 Barasertib
3.33
uM
LJP5
 0.3702 0.0320 0.1166 0.0818
BT-20 Barasertib
10
uM
LJP5
 0.2926 0.0243 -0.0261 0.0712
BT-20 Vemurafenib
0.04
uM
LJP5
 0.9774 0.0246 0.9713 0.0294
BT-20 Vemurafenib
0.12
uM
LJP5
 0.9744 0.0247 0.9684 0.0298
BT-20 Vemurafenib
0.37
uM
LJP5
 0.9695 0.0188 0.9644 0.0204
BT-20 Vemurafenib
1.11
uM
LJP5
 0.9564 0.0294 0.9492 0.0329